+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Latuda"

From
Schizophrenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Schizophrenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
Antipsychotic Drugs: Technologies and Global Markets - Product Thumbnail Image

Antipsychotic Drugs: Technologies and Global Markets

  • Report
  • September 2018
  • 174 Pages
  • Global
From
LATUDA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LATUDA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States, Japan United States, Japan
From
Latuda - API Insight, 2022 - Product Thumbnail Image

Latuda - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Latuda is a medication used to treat mental disorders such as schizophrenia and bipolar disorder. It is a psychotropic drug, meaning it works by altering the levels of certain chemicals in the brain. It is an atypical antipsychotic, meaning it works differently than traditional antipsychotics. It is believed to work by blocking the action of dopamine, a neurotransmitter that is involved in the regulation of mood and behavior. Latuda is a relatively new drug, having been approved by the FDA in 2010. It is available in both oral and injectable forms. It is generally well-tolerated, with few side effects. Common side effects include nausea, headache, and insomnia. The Latuda market is a growing one, with many companies competing for market share. Some of the major players in the market include Sunovion Pharmaceuticals, Otsuka Pharmaceuticals, and Intra-Cellular Therapies. Other companies include Lundbeck, Teva Pharmaceuticals, and Mylan. Show Less Read more